BrainsWay Ltd.
BWAYNASDAQHealthcare● Active
$14.41
+$0.52(+3.71%)
Market Cap$565007315
P/E Ratio—
52W High$17.352
52W Low$5.105
BrainsWay Ltd. (BWAY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BWAY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
$0.12
Est. $0.05 · +140.0%
Revenue
$0.02B
Est. $0.01B · +6.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 2-Quarter EPS Beat Streak
BWAY reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | $0.08 | — | — | — | $0.02B | — |
| ▲ Q2 FY2026 | May 13, 2026 | $0.05 | $0.12 | +140.0% | $0.02B | $0.01B | +6.1% |
| ▲ Q1 FY2026 | Mar 11, 2026 | $0.06 | $0.14 | +133.3% | $0.01B | $0.01B | +3.8% |
| ▼ Q4 FY2025 | Nov 11, 2025 | $0.11 | $0.08 | -27.3% | $0.01B | $0.01B | -3.6% |
| — Q3 FY2025 | Sep 30, 2025 | — | $0.05 | — | $0.01B | — | — |
| ▲ Q2 FY2025 | May 13, 2025 | $0.02 | $0.04 | +100.0% | $0.01B | $0.01B | -5.2% |
| ▲ Q1 FY2025 | Mar 11, 2025 | $0.05 | $0.08 | +60.0% | $0.01B | $0.01B | -0.9% |
| ▲ Q4 FY2024 | Nov 12, 2024 | $0.01 | $0.04 | +207.7% | $0.01B | $0.01B | -3.3% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
$0.08
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Beat
EPS Actual
$0.12
EPS Est.
$0.05
EPS Surpr.
+140.0%
Revenue
$0.02B
Q1 FY2026
Mar 11, 2026Beat
EPS Actual
$0.14
EPS Est.
$0.06
EPS Surpr.
+133.3%
Revenue
$0.01B
Q4 FY2025
Nov 11, 2025Miss
EPS Actual
$0.08
EPS Est.
$0.11
EPS Surpr.
-27.3%
Revenue
$0.01B
Q3 FY2025
Sep 30, 2025
EPS Actual
$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2025
May 13, 2025Beat
EPS Actual
$0.04
EPS Est.
$0.02
EPS Surpr.
+100.0%
Revenue
$0.01B
Q1 FY2025
Mar 11, 2025Beat
EPS Actual
$0.08
EPS Est.
$0.05
EPS Surpr.
+60.0%
Revenue
$0.01B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
$0.04
EPS Est.
$0.01
EPS Surpr.
+207.7%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.08 | $0.08 | $0.08 | 1 |
| Q3 FY2028 | $0.07 | $0.07 | $0.08 | 1 |
| Q2 FY2028 | $0.06 | $0.07 | $0.07 | 1 |
| Q1 FY2028 | $0.06 | $0.07 | $0.07 | 1 |
| Q4 FY2027 | $0.08 | $0.08 | $0.09 | 1 |
| Q3 FY2027 | $0.07 | $0.07 | $0.08 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 13, 2026 | +140.0% | $16.74 | $16.31 | -2.57% |
| ▲ Q1 FY2026 | Mar 11, 2026 | +133.3% | $12.71 | $13.77 | +8.34% |
| ▼ Q4 FY2025 | Nov 11, 2025 | -27.3% | $8.06 | $7.59 | -5.83% |
| — Q3 FY2025 | Sep 30, 2025 | — | $7.65 | $7.54 | -1.44% |
| ▲ Q2 FY2025 | May 13, 2025 | +100.0% | $4.42 | $4.91 | +11.09% |
| ▲ Q1 FY2025 | Mar 11, 2025 | +60.0% | $4.60 | $4.81 | +4.57% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +207.7% | $5.40 | $4.85 | -10.19% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +100.0% | $3.20 | $3.45 | +7.81% |
Q2 FY2026-2.57%
Report Date
May 13, 2026
EPS Beat/Miss
+140.0%
Price Before
$16.74
Price After
$16.31
Q1 FY2026+8.34%
Report Date
Mar 11, 2026
EPS Beat/Miss
+133.3%
Price Before
$12.71
Price After
$13.77
Q4 FY2025-5.83%
Report Date
Nov 11, 2025
EPS Beat/Miss
-27.3%
Price Before
$8.06
Price After
$7.59
Q3 FY2025-1.44%
Report Date
Sep 30, 2025
EPS Beat/Miss
—
Price Before
$7.65
Price After
$7.54
Q2 FY2025+11.09%
Report Date
May 13, 2025
EPS Beat/Miss
+100.0%
Price Before
$4.42
Price After
$4.91
Q1 FY2025+4.57%
Report Date
Mar 11, 2025
EPS Beat/Miss
+60.0%
Price Before
$4.60
Price After
$4.81
Q4 FY2024-10.19%
Report Date
Nov 12, 2024
EPS Beat/Miss
+207.7%
Price Before
$5.40
Price After
$4.85
Q3 FY2024+7.81%
Report Date
Aug 6, 2024
EPS Beat/Miss
+100.0%
Price Before
$3.20
Price After
$3.45
Avg Beat Reaction+3.18%
Avg Miss Reaction-5.83%
Beat Rate6 / 8 quarters
Largest Move+11.09% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BWAY ends December
BrainsWay Ltd. (BWAY) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $0.12 — beating the analyst consensus of $0.05 by +140.0%. BWAY has beaten EPS estimates for 2 consecutive quarters. The next BWAY earnings date is expected around September 1, 2026.
Each quarter, investors track BWAY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BWAY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BWAY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BWAY earnings · 5 questionsBrainsWay Ltd.'s next earnings report is expected around September 1, 2026. BWAY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BWAY historically reports after market close (AMC).
BWAY earnings datewhen is BWAY earningsBWAY next earnings datewhen does BWAY report earningsBWAY earnings calendar
▸ Source: FMP · BrainsWay Ltd. SEC filings · US GAAP · BrainsWay Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026